13D Filing: Sutter Hill Ventures and Cardica Inc (CRDC)

You can access the original SEC filing by clicking here.

Ownership Summary Table

Name Sole Voting Power Shared Voting Power Sole Dispositive Power Shared Dispositive Power Aggregate Amount Owned Power Percent of Class
Sutter Hill Ventures, a California Limited Partnership 296,614 0 296,614 0 296,614 3.3%
William H. Younger, Jr 100,782 296,614 100,782 296,614 397,396 4.5%
Tench Coxe 70,711 296,614 70,711 296,614 367,325 4.1%
James N. White 22,494 296,614 22,494 296,614 319,108 3.6%
Jeffrey W. Bird 20,610 296,614 20,610 296,614 317,224 3.6%
Michael L. Speiser 21,947 296,614 21,947 296,614 318,561 3.6%
Stefan A. Dyckerhoff 4,264 296,614 4,264 296,614 300,878 3.4%
Samuel J. Pullara III 4,264 296,614 4,264 296,614 300,878 3.4%

Page 1 of 14 SEC Filing



 
UNITED STATES
 
 
SECURITIES AND EXCHANGE COMMISSION
 
 
Washington, D.C. 20549
 
     
 
SCHEDULE 13D
 
Under the Securities Exchange Act of 1934
(Amendment No. 1 )*
Cardica, Inc.
(Name of Issuer)
Common Stock
(Title of Class of Securities)
14141R309
(CUSIP Number)
Robert Yin
Sutter Hill Ventures
755 Page Mill Rd., Suite A-200
Palo Alto, CA  94304
650-493-5600
(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)
February 26, 2016
(Date of Event Which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. o
Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See Rule 13d-7 for other parties to whom copies are to be sent.
* The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

Follow Dextera Surgical Inc (NASDAQ:DXTR)

Page 2 of 14 SEC Filing

CUSIP No.   14141R309
 
 
1.
Names of Reporting Persons
Sutter Hill Ventures, a California Limited Partnership
 
 
2.
Check the Appropriate Box if a Member of a Group (See Instructions)
   
(a)
 o
   
(b)
 x
 
 
3.
SEC Use Only
 
 
4.
Source of Funds (See Instructions)
WC
 
 
5.
Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e)     o
 
 
6.
Citizenship or Place of Organization
California
 
Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With
7.
Sole Voting Power
296,614*
 
8.
Shared Voting Power
0
 
9.
Sole Dispositive Power
296,614*
 
10.
Shared Dispositive Power
0
 
 
11.
Aggregate Amount Beneficially Owned by Each Reporting Person
296,614
 
 
12.
Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)   o
 
 
13.
Percent of Class Represented by Amount in Row (11)
3.3%
 
 
14.
Type of Reporting Person (See Instructions)
PN
____________________________
* See Note 1 on Appendix A.
2

Follow Dextera Surgical Inc (NASDAQ:DXTR)

Page 3 of 14 SEC Filing

CUSIP No.   14141R309
 
 
1.
Names of Reporting Persons
William H. Younger, Jr.
 
 
2.
Check the Appropriate Box if a Member of a Group (See Instructions)
   
(a)
 o
   
(b)
 x
 
 
3.
SEC Use Only
 
 
4.
Source of Funds (See Instructions)
PF
 
 
5.
Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e)     o
 
 
6.
Citizenship or Place of Organization
United States
 
Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With
7.
Sole Voting Power
100,782*
 
8.
Shared Voting Power
296,614**
 
9.
Sole Dispositive Power
100,782*
 
10.
Shared Dispositive Power
296,614**
 
 
11.
Aggregate Amount Beneficially Owned by Each Reporting Person
397,396
 
 
12.
Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)   o
 
 
13.
Percent of Class Represented by Amount in Row (11)
4.5%
 
 
14.
Type of Reporting Person (See Instructions)
IN
____________________________
* See Note 3 on Appendix A.
** Includes shares owned by Sutter Hill Ventures, a California Limited Partnership. See Appendix A.
3

Follow Dextera Surgical Inc (NASDAQ:DXTR)

Page 4 of 14 SEC Filing

CUSIP No.   14141R309
 
 
1.
Names of Reporting Persons
Tench Coxe
 
 
2.
Check the Appropriate Box if a Member of a Group (See Instructions)
   
(a)
 o
   
(b)
 x
 
 
3.
SEC Use Only
 
 
4.
Source of Funds (See Instructions)
PF
 
 
5.
Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e)     o
 
 
6.
Citizenship or Place of Organization
United States
 
Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With
7.
Sole Voting Power
70,711*
 
8.
Shared Voting Power
296,614**
 
9.
Sole Dispositive Power
70,711*
 
10.
Shared Dispositive Power
296,614**
 
 
11.
Aggregate Amount Beneficially Owned by Each Reporting Person
367,325
 
 
12.
Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)   o
 
 
13.
Percent of Class Represented by Amount in Row (11)
4.1%
 
 
14.
Type of Reporting Person (See Instructions)
IN
____________________________
* See Note 4 on Appendix A.
** Includes shares owned by Sutter Hill Ventures, a California Limited Partnership. See Appendix A.
4

Follow Dextera Surgical Inc (NASDAQ:DXTR)

Page 5 of 14 SEC Filing

CUSIP No.   14141R309
 
 
1.
Names of Reporting Persons
James N. White
 
 
2.
Check the Appropriate Box if a Member of a Group (See Instructions)
   
(a)
 o
   
(b)
 x
 
 
3.
SEC Use Only
 
 
4.
Source of Funds (See Instructions)
PF
 
 
5.
Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e)     o
 
 
6.
Citizenship or Place of Organization
United States
 
Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With
7.
Sole Voting Power
22,494*
 
8.
Shared Voting Power
296,614**
 
9.
Sole Dispositive Power
22,494*
 
10.
Shared Dispositive Power
296,614**
 
 
11.
Aggregate Amount Beneficially Owned by Each Reporting Person
319,108
 
 
12.
Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)   o
 
 
13.
Percent of Class Represented by Amount in Row (11)
3.6%
 
 
14.
Type of Reporting Person (See Instructions)
IN
____________________________
* See Note 5 on Appendix A.
** Includes shares owned by Sutter Hill Ventures, a California Limited Partnership. See Appendix A.
5

Follow Dextera Surgical Inc (NASDAQ:DXTR)

Page 6 of 14 SEC Filing

CUSIP No.   14141R309
 
 
1.
Names of Reporting Persons
Jeffrey W. Bird
 
 
2.
Check the Appropriate Box if a Member of a Group (See Instructions)
   
(a)
 o
   
(b)
 x
 
 
3.
SEC Use Only
 
 
4.
Source of Funds (See Instructions)
PF
 
 
5.
Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e)     o
 
 
6.
Citizenship or Place of Organization
United States
 
Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With
7.
Sole Voting Power
20,610*
 
8.
Shared Voting Power
296,614**
 
9.
Sole Dispositive Power
20,610*
 
10.
Shared Dispositive Power
296,614**
 
 
11.
Aggregate Amount Beneficially Owned by Each Reporting Person
317,224
 
 
12.
Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)   o
 
 
13.
Percent of Class Represented by Amount in Row (11)
3.6%
 
 
14.
Type of Reporting Person (See Instructions)
IN
____________________________
* See Note 6 on Appendix A.
** Includes shares owned by Sutter Hill Ventures, a California Limited Partnership. See Appendix A.
6

Follow Dextera Surgical Inc (NASDAQ:DXTR)

Page 7 of 14 SEC Filing

CUSIP No.  14141R309
 
 
1.
Names of Reporting Persons
Michael L. Speiser
 
 
2.
Check the Appropriate Box if a Member of a Group (See Instructions)
   
(a)
 o
   
(b)
 x
 
 
3.
SEC Use Only
 
 
4.
Source of Funds (See Instructions)
PF
 
 
5.
Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e)     o
 
 
6.
Citizenship or Place of Organization
United States
 
Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With
7.
Sole Voting Power
21,947*
 
8.
Shared Voting Power
296,614**
 
9.
Sole Dispositive Power
21,947*
 
10.
Shared Dispositive Power
296,614**
 
 
11.
Aggregate Amount Beneficially Owned by Each Reporting Person
318,561
 
 
12.
Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)   o
 
 
13.
Percent of Class Represented by Amount in Row (11)
3.6%
 
 
14.
Type of Reporting Person (See Instructions)
IN
____________________________
* See Note 7 on Appendix A.
** Includes shares owned by Sutter Hill Ventures, a California Limited Partnership. See Appendix A.
7

Follow Dextera Surgical Inc (NASDAQ:DXTR)

Page 8 of 14 SEC Filing

CUSIP No.  14141R309
 
 
1.
Names of Reporting Persons
Stefan A. Dyckerhoff
 
 
2.
Check the Appropriate Box if a Member of a Group (See Instructions)
   
(a)
 o
   
(b)
 x
 
 
3.
SEC Use Only
 
 
4.
Source of Funds (See Instructions)
PF
 
 
5.
Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e)     o
 
 
6.
Citizenship or Place of Organization
German citizen (U.S. permanent resident)
 
Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With
7.
Sole Voting Power
4,264*
 
8.
Shared Voting Power
296,614**
 
9.
Sole Dispositive Power
4,264*
 
10.
Shared Dispositive Power
296,614**
 
 
11.
Aggregate Amount Beneficially Owned by Each Reporting Person
300,878
 
 
12.
Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)   o
 
 
13.
Percent of Class Represented by Amount in Row (11)
3.4%
 
 
14.
Type of Reporting Person (See Instructions)
IN
____________________________
* See Note 8 on Appendix A.
** Includes shares owned by Sutter Hill Ventures, a California Limited Partnership. See Appendix A.
8

Follow Dextera Surgical Inc (NASDAQ:DXTR)

Page 9 of 14 SEC Filing

CUSIP No.  14141R309
 
 
1.
Names of Reporting Persons
Samuel J. Pullara III
 
 
2.
Check the Appropriate Box if a Member of a Group (See Instructions)
   
(a)
 o
   
(b)
 x
 
 
3.
SEC Use Only
 
 
4.
Source of Funds (See Instructions)
PF
 
 
5.
Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e)     o
 
 
6.
Citizenship or Place of Organization
United States
 
Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With
7.
Sole Voting Power
4,264*
 
8.
Shared Voting Power
296,614**
 
9.
Sole Dispositive Power
4,264*
 
10.
Shared Dispositive Power
296,614**
 
 
11.
Aggregate Amount Beneficially Owned by Each Reporting Person
300,878
 
 
12.
Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)   o
 
 
13.
Percent of Class Represented by Amount in Row (11)
3.4%
 
 
14.
Type of Reporting Person (See Instructions)
IN
____________________________
* See Note 9 on Appendix A.
** Includes shares owned by Sutter Hill Ventures, a California Limited Partnership. See Appendix A.
9

Follow Dextera Surgical Inc (NASDAQ:DXTR)

Page 10 of 14 SEC Filing

 
Explanatory Note:
 
This Schedule 13D/A (the “Schedule 13D/A”) is being filed by the Reporting Persons (as defined below) to amend the Schedule 13D originally filed with the Securities and Exchange Commission (the “Commission”) on March 29, 2013 (the “Original Schedule 13D”) to report the distribution of shares of Common Stock of the Issuer by SHV (as defined below) to the managing members of its general partner in accordance with the terms of its partnership agreement. The Original Schedule 13D is hereby amended and supplemented as detailed below, and, except as specifically amended and supplemented hereby, the Original Schedule 13D remains in full force and effect.
The share ownership reported herein gives effect to a one-for-ten reverse stock split of the Issuer’s Common Stock effected on February 17, 2016.
Item 2.
Identity and Background
 
Item 2 of the Original Schedule 13D is hereby amended and restated in its entirety as follows:
 
(a)
This Schedule is filed by Sutter Hill Ventures, a California Limited Partnership (“SHV”), William H. Younger, Jr., Tench Coxe, James N. White, Jeffrey W. Bird, Michael L. Speiser, Stefan A. Dyckerhoff and Samuel J. Pullara III  (collectively, the “Reporting Persons”).
 
(b)
The business address for each of the Reporting Persons is 755 Page Mill Rd., Suite A-200, Palo Alto, CA 94304.
 
(c)
SHV’s principal business is venture capital investing.  The other Reporting Persons’ present principal occupation or employment is serving as a managing director of the general partner of SHV. The principal business address of the organization in which such employment is conducted is 755 Page Mill Rd., Suite A-200, Palo Alto, CA 94304.
 
(d)
and (e)  None of the Reporting Persons have, during the past five years, been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors). None of the Reporting Persons have, during the last five years, been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws.
 
(f)
SHV is a California limited partnership.  Each of the other Reporting Persons is a U.S. citizen except Mr. Dyckerhoff who is a German citizen and U.S. permanent resident.
     
10

Follow Dextera Surgical Inc (NASDAQ:DXTR)

Page 11 of 14 SEC Filing

Item 4.
Purpose of Transaction
 
Item 4 of the Original Schedule 13D is hereby amended and supplemented by adding the following at the end thereof:
On February 26, 2016, in accordance with the terms of the its partnership agreement, SHV distributed 44,665 shares of the Issuer’s Common Stock to the managing directors of its general partner.
   
Item 5.
Interest in Securities of the Issuer
   
 
Item 5 of the Original Schedule 13D is hereby amended and restated in its entirety as follows:
 
(a) — (b) The responses to Nos. 7 — 13 of the several cover pages of the Schedule are incorporated herein by reference. Additionally, the information included in Appendix A hereto is also incorporated herein by reference.
   
  (c)  As a result of the distribution by SHV on February 26, 2016, the following Reporting Persons received the following shares:
Reporting Person
  
Number of Shares Received in Distribution
 
William H. Younger, Jr.
  
 
56
  
Tench Coxe
  
 
2,654
  
James N. White
  
 
6,084
  
Jeffrey W. Bird
  
 
6,948
  
Michael L. Speiser
   
21,099
 
Stefan A. Dyckerhoff
  
 
2,421
  
Samuel J. Pullara III
   
2,421
 
 
 
Except as set forth above, none of the Reporting Persons has effected any transactions in the Common Stock during the past 60 days.
 
(d) The Reporting Persons know of no other person having the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the shares beneficially owned by the Reporting Persons.
(e) As of February 26, 2016, the Reporting Persons no longer beneficially owned 5% of the Issuer’s outstanding Common Stock.
 
 
11

Follow Dextera Surgical Inc (NASDAQ:DXTR)

Page 12 of 14 SEC Filing

Signatures
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
March 1, 2016
 
SUTTER HILL VENTURES, A CALIFORNIA LIMITED
Date
PARTNERSHIP
   
   
 
By:
/s/ Robert Yin
   
Robert Yin, Attorney-in-Fact for William H. Younger, Jr., managing director of the general partner
   
   
 
By:
/s/ Robert Yin
   
Robert Yin, Attorney-in-Fact for William H. Younger, Jr.
   
 
By:
/s/ Robert Yin
 
 
Robert Yin, Attorney-in-Fact for Tench Coxe
   
 
By:
/s/ Robert Yin
 
 
Robert Yin, Attorney-in-Fact for James N. White
     
 
By:
/s/ Robert Yin
 
 
Robert Yin, Attorney-in-Fact for Jeffrey W. Bird
     
 
By:
/s/ Robert Yin
 
 
Robert Yin, Attorney-in-Fact for Michael L. Speiser
     
 
By:
/s/ Robert Yin
 
 
Robert Yin, Attorney-in-Fact for Stefan A. Dyckerhoff
     
 
By:
/s/ Robert Yin
   
Robert Yin, Attorney-in-Fact for Samuel J. Pullara III
12

Follow Dextera Surgical Inc (NASDAQ:DXTR)

Page 13 of 14 SEC Filing

APPENDIX A TO SCHEDULE 13D – CARDICA, INC.
   
Aggregate Number of
         
   
Shares Beneficially Owned
     
% of
 
Name of Originator
 
Individual
     
Aggregate
     
Total Shares
 
                       
Sutter Hill Ventures, a California Limited Partnership
 
296,614
 
Note 1
         
3.3
%
                       
                       
William H. Younger, Jr.
 
100,782
 
Note 3
         
1.1
%
           
397,396
 
Note 2
 
4.5
%
                       
Tench Coxe
 
70,711
 
Note 4
         
0.8
%
           
367,325
 
Note 2
 
4.1
%
                       
James N. White
 
22,494
 
Note 5
         
0.3
%
           
319,108
 
Note 2
 
3.6
%
                       
Jeffrey W. Bird
 
20,610
 
Note 6
         
0.2
%
           
317,224
 
Note 2
 
3.6
%
                       
Michael L. Speiser
 
21,947
 
Note 7
         
0.2
%
           
318,561
 
Note 2
 
3.6
%
                       
Stefan A. Dyckerhoff
 
4,264
 
Note 8
         
0.0
%
           
300,878
 
Note 2
 
3.4
%
                       
Samuel J. Pullara III
 
4,264
 
Note 9
         
0.0
%
           
300,878
 
Note 2
 
3.4
%
13

Follow Dextera Surgical Inc (NASDAQ:DXTR)

Page 14 of 14 SEC Filing

____________________________
Note 1:  Comprised of 296,614 common shares held directly by Sutter Hill Ventures, a California Limited Partnership (“SHV”).
Note 2:  Includes individual shares plus all shares held by SHV.  The individual is a managing director of the general partner of SHV.
Note 3:  Comprised of 26,468 shares held in The William H. Younger, Jr. Revocable Trust of which the reporting person is the trustee, 17,286 shares held by a retirement trust for the benefit of the reporting person, 44,415 shares held by Yovest, L.P. of which the reporting person is the trustee of a trust which is the general partner, 12,613 shares of director’s options which are fully vested and exercisable within 60 days after February 26, 2016.
Note 4:  Comprised of 26,390 shares held in The Coxe Revocable Trust of which the reporting person is a trustee, 35,815 shares held by a retirement trust for the benefit of the reporting person, 2,169 shares held in The Tamerlane Charitable Remainder Unitrust of which the reporting person is the trustee and 6,337 shares held by Rooster Partners, L.P. of which the reporting person is a trustee of a trust which is the general partner.
Note 5: Comprised of 22,187 shares held in The White Revocable Trust of which the reporting person is a trustee and 307 shares held by a retirement trust for the benefit of the reporting person.
Note 6: Comprised of 20,610 shares held in the Jeffrey W. and Christina R. Bird Trust of which the reporting person is a trustee.
Note 7: Comprised of 21,867 shares held in the Speiser Trust Agreement of which the reporting person is a trustee and 80 shares held by a retirement trust for the benefit of the reporting person.
Note 8: Comprised of 4,264 shares held in the Dyckerhoff 2001 Revocable Trust of which the reporting person is a trustee.
Note 9: Comprised of 4,264 shares held in The Pullara Revocable Trust of which the reporting person is a trustee.
14



Follow Dextera Surgical Inc (NASDAQ:DXTR)